ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for RGEN

Stock NameRepligen Corporation
TickerRGEN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS7599161095
LEI54930006QJ0T5AUO1E71

Show aggregate RGEN holdings

News associated with RGEN

Repligen Corporation (NASDAQ:RGEN) Receives Average Recommendation of “Moderate Buy” from Analysts
Repligen Corporation (NASDAQ:RGEN – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price […] - 2025-09-19 03:14:49
Repligen Corporation (NASDAQ:RGEN) Receives $169.45 Average Target Price from Analysts
Repligen Corporation (NASDAQ:RGEN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven ratings firms that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price target […] - 2025-08-28 03:14:53
Rep. Lisa C. McClain Sells Off Shares of Repligen Corporation (NASDAQ:RGEN)
Representative Lisa C. McClain (R-Michigan) recently sold shares of Repligen Corporation (NASDAQ:RGEN). In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Repligen stock on June 17th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account. Representative Lisa C. McClain also recently made […] - 2025-08-21 03:08:43
Swiss National Bank Sells 1,500 Shares of Repligen Corporation (NASDAQ:RGEN)
Swiss National Bank decreased its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,200 shares of the biotechnology company’s stock after selling 1,500 shares during the quarter. Swiss […] - 2025-08-15 05:44:53
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. lifted its position in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 4.4% in the first quarter, Holdings Channel reports. The firm owned 3,632 shares of the biotechnology company’s stock after purchasing an additional 152 shares during the period. PNC Financial Services Group Inc.’s holdings in Repligen were worth […] - 2025-08-14 05:32:58
Wealthquest Corp Invests $264,000 in Repligen Corporation (NASDAQ:RGEN)
Wealthquest Corp acquired a new position in Repligen Corporation (NASDAQ:RGEN – Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,077 shares of the biotechnology company’s stock, valued at approximately $264,000. Other hedge funds have also recently bought and sold shares of the […] - 2025-08-01 04:44:56
Thornburg Investment Management Inc. Has $4.29 Million Position in Repligen Corporation (NASDAQ:RGEN)
Thornburg Investment Management Inc. trimmed its stake in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 4.7% in the first quarter, Holdings Channel.com reports. The firm owned 33,720 shares of the biotechnology company’s stock after selling 1,646 shares during the quarter. Thornburg Investment Management Inc.’s holdings in Repligen were worth $4,291,000 at the end […] - 2025-07-30 04:44:45
Repligen Corporation (NASDAQ:RGEN) Shares Bought by Signaturefd LLC
Signaturefd LLC raised its position in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 65.3% during the 1st quarter, Holdings Channel reports. The firm owned 324 shares of the biotechnology company’s stock after buying an additional 128 shares during the quarter. Signaturefd LLC’s holdings in Repligen were worth $41,000 as of its most recent […] - 2025-07-24 05:00:47
Ballentine Partners LLC Has $224,000 Stock Holdings in Repligen Corporation (NASDAQ:RGEN)
Ballentine Partners LLC lessened its stake in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 6.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,759 shares of the biotechnology company’s stock after selling 120 shares during the period. […] - 2025-07-17 06:05:50
Allworth Financial LP Sells 733 Shares of Repligen Corporation (NASDAQ:RGEN)
Allworth Financial LP reduced its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 47.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 809 shares of the biotechnology company’s stock after selling 733 shares during the quarter. Allworth Financial LP’s […] - 2025-07-17 05:25:12
Repligen Corporation (NASDAQ:RGEN) Shares Bought by State of Michigan Retirement System
State of Michigan Retirement System grew its holdings in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 0.8% in the 1st quarter, Holdings Channel reports. The fund owned 12,453 shares of the biotechnology company’s stock after acquiring an additional 100 shares during the period. State of Michigan Retirement System’s holdings in Repligen were worth […] - 2025-07-15 06:28:23
DekaBank Deutsche Girozentrale Decreases Holdings in Repligen Corporation (NASDAQ:RGEN)
DekaBank Deutsche Girozentrale trimmed its holdings in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 1.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,750 shares of the biotechnology company’s stock after selling 80 shares during the period. DekaBank Deutsche […] - 2025-07-14 05:34:50
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by Teacher Retirement System of Texas
Teacher Retirement System of Texas grew its holdings in Repligen Corporation (NASDAQ:RGEN – Free Report) by 61.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 15,811 shares of the biotechnology company’s stock after buying an additional 6,036 shares during the period. Teacher Retirement System of Texas’ holdings in Repligen were worth $2,012,000 at the […] - 2025-07-11 05:50:59
Repligen (NASDAQ:RGEN) Price Target Cut to $130.00 by Analysts at Evercore ISI
Repligen (NASDAQ:RGEN – Free Report) had its target price cut by Evercore ISI from $140.00 to $130.00 in a report issued on Tuesday morning,Benzinga reports. They currently have an in-line rating on the biotechnology company’s stock. A number of other brokerages have also recently issued reports on RGEN. Wall Street Zen cut shares of Repligen […] - 2025-07-11 03:08:46
Principal Financial Group Inc. Boosts Holdings in Repligen Corporation (NASDAQ:RGEN)
Principal Financial Group Inc. grew its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 55.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 186,715 shares of the biotechnology company’s stock after purchasing an additional 66,808 shares during the period. Principal Financial Group Inc.’s holdings in Repligen were worth $23,758,000 at the end […] - 2025-07-09 05:51:35
New York State Teachers Retirement System Has $6.49 Million Stake in Repligen Corporation (NASDAQ:RGEN)
New York State Teachers Retirement System reduced its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 5.4% during the first quarter, HoldingsChannel reports. The firm owned 51,032 shares of the biotechnology company’s stock after selling 2,900 shares during the period. New York State Teachers Retirement System’s holdings in Repligen were worth $6,493,000 at the […] - 2025-07-06 06:14:54
Mirae Asset Global Investments Co. Ltd. Purchases 11,193 Shares of Repligen Corporation (NASDAQ:RGEN)
Mirae Asset Global Investments Co. Ltd. boosted its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 60.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 29,822 shares of the biotechnology company’s stock after purchasing an additional 11,193 shares during the period. Mirae Asset Global Investments […] - 2025-07-02 06:04:50
Retirement Systems of Alabama Acquires 86 Shares of Repligen Corporation (NASDAQ:RGEN)
Retirement Systems of Alabama boosted its holdings in Repligen Corporation (NASDAQ:RGEN – Free Report) by 0.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 63,418 shares of the biotechnology company’s stock after acquiring an additional 86 shares during the period. Retirement […] - 2025-06-24 05:32:52
Analysts Anticipate IYH To Hit $66
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:47:36
Analysts Anticipate IYH To Hit $66
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:47:26
Parallel Advisors LLC Reduces Holdings in Repligen Co. (NASDAQ:RGEN)
Parallel Advisors LLC reduced its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 30.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 285 shares of the biotechnology company’s stock after selling 123 shares during the quarter. Parallel Advisors LLC’s holdings in Repligen were worth $36,000 at the end of the most recent quarter. […] - 2025-06-10 04:46:53
Squarepoint Ops LLC Sells 81,814 Shares of Repligen Co. (NASDAQ:RGEN)
Squarepoint Ops LLC reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 85.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,291 shares of the biotechnology company’s stock after selling 81,814 shares during the quarter. Squarepoint Ops LLC’s holdings in Repligen were worth $2,057,000 as of its most […] - 2025-05-29 05:52:48
ProShare Advisors LLC Has $351,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN)
ProShare Advisors LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 7.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,438 shares of the biotechnology company’s stock after acquiring an additional 167 shares during the period. ProShare Advisors LLC’s […] - 2025-05-29 05:08:49
Tidal Investments LLC Decreases Stock Holdings in Repligen Co. (NASDAQ:RGEN)
Tidal Investments LLC lowered its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 60.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,437 shares of the biotechnology company’s stock after selling 6,712 shares during the period. Tidal […] - 2025-05-28 05:52:53
The Math Shows MDY Can Go To $634
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-22 07:58:15
Repligen Co. (NASDAQ:RGEN) Shares Sold by Bank of America Corp DE
Bank of America Corp DE decreased its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 36.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 277,947 shares of the biotechnology company’s stock after selling 158,404 shares during the period. Bank of America […] - 2025-05-16 06:38:55
Financial Survey: Repligen (NASDAQ:RGEN) & Maze Therapeutics (NASDAQ:MAZE)
Repligen (NASDAQ:RGEN – Get Free Report) and Maze Therapeutics (NASDAQ:MAZE – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Analyst Recommendations This is a summary of recent recommendations […] - 2025-05-16 02:09:10
Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright
Repligen (NASDAQ:RGEN – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $180.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would suggest a potential upside of 38.04% from the stock’s previous close. […] - 2025-05-07 02:58:48
Repligen (NASDAQ:RGEN) Given New $190.00 Price Target at JPMorgan Chase & Co.
Repligen (NASDAQ:RGEN – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $200.00 to $190.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the biotechnology company’s stock. RGEN has been the subject of several other reports. Wolfe Research raised shares of Repligen […] - 2025-04-30 05:32:52
Repligen (NASDAQ:RGEN) Upgraded by Wolfe Research to Outperform Rating
Wolfe Research upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a peer perform rating to an outperform rating in a report published on Tuesday, Marketbeat.com reports. They currently have $160.00 price objective on the biotechnology company’s stock. A number of other research firms have also weighed in on RGEN. Royal Bank of Canada upped […] - 2025-04-30 05:32:47

iShares Healthcare Innovation UCITS ETF USD (Acc) RGEN holdings

DateNumber of RGEN Shares HeldBase Market Value of RGEN SharesLocal Market Value of RGEN SharesChange in RGEN Shares HeldChange in RGEN Base ValueCurrent Price per RGEN Share HeldPrevious Price per RGEN Share Held
2025-11-27 (Thursday)63,360USD 10,845,965USD 10,845,9650USD 0 USD 171.18 USD 171.18
2025-11-26 (Wednesday)63,360USD 10,845,965RGEN holding decreased by -36749USD 10,845,9650USD -36,749 USD 171.18 USD 171.76
2025-11-25 (Tuesday)63,360USD 10,882,714RGEN holding increased by 285120USD 10,882,7140USD 285,120 USD 171.76 USD 167.26
2025-11-24 (Monday)63,360USD 10,597,594RGEN holding increased by 300960USD 10,597,5940USD 300,960 USD 167.26 USD 162.51
2025-11-21 (Friday)63,360USD 10,296,634RGEN holding increased by 516384USD 10,296,6340USD 516,384 USD 162.51 USD 154.36
2025-11-20 (Thursday)63,360USD 9,780,250RGEN holding decreased by -45619USD 9,780,2500USD -45,619 USD 154.36 USD 155.08
2025-11-19 (Wednesday)63,360USD 9,825,869RGEN holding increased by 127987USD 9,825,8690USD 127,987 USD 155.08 USD 153.06
2025-11-18 (Tuesday)63,360USD 9,697,882RGEN holding increased by 257242USD 9,697,8820USD 257,242 USD 153.06 USD 149
2025-11-17 (Monday)63,360USD 9,440,640RGEN holding decreased by -213523USD 9,440,6400USD -213,523 USD 149 USD 152.37
2025-11-14 (Friday)63,360RGEN holding decreased by -548USD 9,654,163RGEN holding increased by 32175USD 9,654,163-548USD 32,175 USD 152.37 USD 150.56
2025-11-13 (Thursday)63,908USD 9,621,988RGEN holding decreased by -476115USD 9,621,9880USD -476,115 USD 150.56 USD 158.01
2025-11-12 (Wednesday)63,908USD 10,098,103RGEN holding increased by 292059USD 10,098,1030USD 292,059 USD 158.01 USD 153.44
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RGEN by Blackrock for IE00BYZK4776

Show aggregate share trades of RGEN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-14SELL-548154.790144.810 145.808USD -79,903 138.98 Loss of -3,744 on sale
2025-10-24SELL-542166.330169.870 169.516USD -91,878 138.02 Loss of -17,073 on sale
2025-09-11BUY271119.510122.710 122.390USD 33,168 137.67
2025-07-08SELL-271128.560129.380 129.298USD -35,040 139.16 Profit of 2,673 on sale
2025-06-24SELL-271123.350125.030 124.862USD -33,838 140.07 Profit of 4,122 on sale
2025-06-23SELL-271120.110120.280 120.263USD -32,591 140.22 Profit of 5,407 on sale
2025-06-11SELL-271132.000135.300 134.970USD -36,577 141.22 Profit of 1,692 on sale
2025-05-30SELL-271118.070121.880 121.499USD -32,926 142.22 Profit of 5,615 on sale
2025-05-21BUY271120.210126.190 125.592USD 34,035 143.55
2025-05-14SELL-1,626128.040134.250 133.629USD -217,281 144.17 Profit of 17,138 on sale
2025-04-30SELL-271137.990139.540 139.385USD -37,773 145.26 Profit of 1,593 on sale
2025-04-28SELL-271143.630148.380 147.905USD -40,082 145.34 Loss of -696 on sale
2025-04-25SELL-271144.750145.960 145.839USD -39,522 145.34 Loss of -134 on sale
2025-04-11SELL-1,626122.860123.240 123.202USD -200,326 146.41 Profit of 37,730 on sale
2025-04-08SELL-813108.890122.690 121.310USD -98,625 147.46 Profit of 21,256 on sale
2025-04-07BUY772116.110121.840 121.267USD 93,618 147.82
2025-03-31SELL-532127.240131.160 130.768USD -69,569 148.95 Profit of 9,673 on sale
2025-03-21SELL-532140.020140.390 140.353USD -74,668 149.70 Profit of 4,970 on sale
2025-03-12SELL-266145.370149.660 149.231USD -39,695 150.10 Profit of 232 on sale
2025-02-28SELL-266159.260160.050 159.971USD -42,552 149.67 Loss of -2,740 on sale
2025-02-25BUY266161.470165.470 165.070USD 43,909 149.12
2025-02-20SELL-266162.670169.000 168.367USD -44,786 148.41 Loss of -5,307 on sale
2025-02-19BUY532150.730151.320 151.261USD 80,471 148.37
2025-02-18BUY266145.180149.040 148.654USD 39,542 148.43
2024-12-30BUY649143.810145.030 144.908USD 94,045 142.79
2024-12-06SELL-262149.200150.560 150.424USD -39,411 141.87 Loss of -2,241 on sale
2024-12-04SELL-262149.090150.780 150.611USD -39,460 141.60 Loss of -2,361 on sale
2024-12-03SELL-524148.500149.810 149.679USD -78,432 141.34 Loss of -4,367 on sale
2024-11-22BUY599142.580145.210 144.947USD 86,823 139.00
2024-11-21SELL-260141.760142.110 142.075USD -36,940 138.85 Loss of -838 on sale
2024-11-20SELL-261138.900139.200 139.170USD -36,323 138.85 Loss of -84 on sale
2024-11-19SELL-261128.490128.980 128.931USD -33,651 139.46 Profit of 2,748 on sale
2024-11-18SELL-1,036123.410126.250 125.966USD -130,501 140.46 Profit of 15,017 on sale
2024-11-12SELL-259148.590154.480 153.891USD -39,858 139.92 Loss of -3,619 on sale
2024-11-07SELL-259143.880146.350 146.103USD -37,841 139.55 Loss of -1,696 on sale
2024-11-05SELL-518145.950146.030 146.022USD -75,639 138.39 Loss of -3,951 on sale
2024-10-28SELL-259137.210138.240 138.137USD -35,777 140.29 Profit of 558 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RGEN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19184,8300275,18767.2%
2025-09-18149,326150235,41163.4%
2025-09-17244,2100450,06254.3%
2025-09-16244,8040507,88348.2%
2025-09-1582,951200234,57635.4%
2025-09-12106,2140244,49443.4%
2025-09-1189,32813192,44246.4%
2025-09-10178,6915413,00343.3%
2025-09-0970,869300226,62931.3%
2025-09-08120,724301294,13341.0%
2025-09-05226,84279378,40359.9%
2025-09-04146,7760331,18244.3%
2025-09-0399,82871193,76451.5%
2025-09-0284,4330164,31051.4%
2025-08-2991,080373217,77041.8%
2025-08-28141,6900402,89835.2%
2025-08-2740,5357145,81927.8%
2025-08-2674,674814199,53837.4%
2025-08-2560,55788144,20642.0%
2025-08-22123,02724289,12642.6%
2025-08-2188,53618155,76856.8%
2025-08-2092,1092192,27247.9%
2025-08-19126,38215253,04149.9%
2025-08-1889,3780179,19049.9%
2025-08-15128,4545231,97655.4%
2025-08-14174,5483296,57858.9%
2025-08-13115,929481251,93546.0%
2025-08-12156,45720400,25839.1%
2025-08-1194,4552,643220,58542.8%
2025-08-0881,3830276,03729.5%
2025-08-0773,5050260,65928.2%
2025-08-06119,5340512,18923.3%
2025-08-0578,097169261,75729.8%
2025-08-0476,311741262,10129.1%
2025-08-01156,1670408,79838.2%
2025-07-31171,9375403,96642.6%
2025-07-30208,5310613,29734.0%
2025-07-29329,89441,013,56432.5%
2025-07-28132,6333,387367,56436.1%
2025-07-25113,2590346,38232.7%
2025-07-24187,6010365,36151.3%
2025-07-23177,6200666,40226.7%
2025-07-22269,18928,300659,38140.8%
2025-07-21144,183270582,43224.8%
2025-07-18155,435769451,13934.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.